(4-(N-(2-((tert-Butoxycarbonyl)amino)ethyl)sulfamoyl)phenyl)boronic acid, 96%, 100mg

4-(Hydroxymethyl)-1-(3-(trifluoromethyl)phenyl)pyrrolidin-2-one, 98%, 250mg

Ulixertinib, 250mg

3-(Aminomethyl)-4-methoxy-6-methylpyridin-2-ol, 95.0%, 5g

1-Oxo-2,3-dihydro-1H-indene-4-carbonitrile, 98.0%, 1g

4-Oxo-4-(2-trifluoromethylphenyl)butyric acid, 97.0%, 1g

7-Oxo-7-(4-isopropoxyphenyl)heptanoic acid, 97.0%, 1g

2-Chloro-6-methoxyquinoline, 95.0%, 25g

3-Chloro-2-nitroaniline, 98.0%, 100g

2,3,4-Trifluorobenzonitrile>98.0%(GC)1g

N-Cyclopropyl-N-tetrahydro-2H-pyran-4ylamine, 95.0%, 10g

6-chloro-{N}-(4-fluorobenzyl)pyridazin-3-amine, 95.0%, 1g

(3S,6S)-5-[(tert-Butoxy)carbonyl]-1,1-difluoro-5-azaspiro[2.4]heptane-6-carboxylic acid, 97%, 250mg